Media

May 12, 2025

Chronic Illness and The Immune System: Chronic Illness and The Immune System: Could ViraxImmune™ Offer a Critical Diagnostic Breakthrough?

A recent Wall Street Journal commentary by Yale immunologist Akiko Iwasaki and cardiologist Harlan Krumholz highlights how immune dysfunction following infection may drive a spectrum of chronic diseases—including long COVID,

April 28, 2025

Nigel McCracken, Virax COO, Discusses the New Frontier in Immune Diagnostics with The Scientist in This Innovation Spotlight.

April 24, 2025

Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmExec.com Interview.

April 23, 2025

In His Latest PharmExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.

April 17, 2025

Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.

March 18, 2025

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

March 13, 2025

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

March 12, 2025

Virax Biolabs Presentation from the 19th World Immune Regulation Meeting: “Evaluation of T cell dysfunction in Post Acute Infection Syndromes”

Dr. Nigel McCracken, our Chief Operating Officer, will present on “Evaluation of T cell dysfunction in Post Acute Infection Syndromes” at the 19th World Immune Regulation Meeting (WIRM) in Davos,

March 5, 2025

Virax Biolabs to Present at 19th World Immune Regulation Meeting

March 4, 2025

Tune in now to listen to Dr. Nigel McCracken talk about “The Power of T Cell Immunology: Early Diagnosis, Immunotherapy, & the Future of Global Health” on the Finding Genius podcast

March 3, 2025

Join us for Inside Precision Medicine’s FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.

One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American

February 26, 2025

“Preparing for Potential Vaccine Regulatory Changes”: Virax CEO, James Foster, discusses how the industry is preparing for potential regulatory changes to vaccine policy

Article by Mike Hollan